Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...

January is Glaucoma Awareness Month. Glaucoma is an extremely painful eye disease that can affect the eyes of all mammals, not just humans, dogs, cats (and horses!) are included.

Pravin U. Dugel, MD, Ocular’s Executive Chairman, President and CEO, will provide an update regarding the enrollment status of SOL-R, the Company’s second registrational trial of AXPAXLI™ for the ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The OHTS-EGPS prediction model provides modestly predictive data for glaucoma conversion for some patients with ocular hypertension.

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

Some patients with ocular hypertension who develop primary open angle glaucoma experience rapid visual field loss.